您当前的位置:
HQL 79
目录号: PC15233 纯度: ≥98%
CAS No. :162641-16-9
商品编号 规格 价格 会员价 是否有货 数量
PC15233-5mg 5mg ¥2469.60 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
HQL 79
中文别名
4-(二苯基甲氧基)-1-[3-(2H-四氮唑-5-基)丙基]哌啶;4-二苯基甲氧基-1-[3-(1H-四唑)丙基]-哌啶
英文名称
HQL 79
英文别名
Piperidine,4-(diphenylmethoxy)-1-[3-(2H-tetrazol-5-yl)propyl]-;1-(3-(1H-TETRAZOL-5-YL)PROPYL)-4-(BENZHYDRYLOXY)PIPERIDINE;4-benzhydryloxy-1-[3-(2H-tetrazol-5-yl)propyl]piperidine;HQL 79;HQL-79;HQL-79 HCl;2cvd;4-Benzhydryloxy-1-[3-(1H-tetrazol-5-yl)-propyl]-piperidine;HQL;HQL-97;4-(Diphenylmethoxy)-1-(3-2H-tetrazol-5-yl)propyl]-piperidine;4-(DIPHENYLMETHOXY)-1-[3-(1H-TETRAZOL-5-YL)PROPYL]-PIPERIDINE
Cas No.
162641-16-9
分子式
C22H27N5O
分子量
377.48
包装储存
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
生物活性

HQL-79, a potent, selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor, highly selectively inhibits the synthesis of PGD2, and acts as an anti-allergic agent, with a Kd of 0.8 μM and an IC50 of 6 μM. Shows no obvious effect on COX-1, COX-2, m-PGES, or L-PGDS.

性状

Solid

IC50 & Target[1][2]

IC50: 6 μM (H-PGDS)
Kd: 0.8 μM (H-PGDS)

体外研究(In Vitro)

HQL-79 is a competitive inhibitor against substrate PGH2 and a non-competitive one against GSH.

Medlife has not independently confirmed the accuracy of these methods. They are for reference only.

运输条件

Room temperature or refrigerated transportation.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2